NASDAQ
LexaGene Holdings Inc. (LXXGF) has a price/sales ratio of 366.39x as of Friday, May 22, 2026. This represents a 285.75% increase compared to its 12-month average of 94.98x. The price-to-sales ratio evaluates a company's stock price relative to its revenue, useful for valuing companies with little or no earnings.
No price data available for this timeframe.